{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-057817","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2023-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.192249+00:00","generated_at":"2026-06-15T09:59:50.086911+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"PowerUp Acquisition enters additional Non-Redemption Agreements covering 750,000 shares for extension vote","bullets":["Five additional Non-Redemption Agreements with unaffiliated third parties covering 750,000 Class A ordinary shares.","Sponsor to transfer 375,000 Class B ordinary shares to investors post-business combination if shares held through meeting.","Agreements increase funds remaining in trust after extraordinary general meeting to approve extension to May 23, 2024.","Total non-redeemed shares now 900,000 (previous 150,000 + 750,000) under all Non-Redemption Agreements."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-057817","json":"https://secwatch.observer/filing/0001104659-23-057817.json","markdown":"https://secwatch.observer/filing/0001104659-23-057817.md","text":"https://secwatch.observer/filing/0001104659-23-057817.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000110465923057817/0001104659-23-057817-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000110465923057817/tm2315181d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T09:59:50.086911+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}